Skip to main content
. Author manuscript; available in PMC: 2018 May 22.
Published in final edited form as: Neurotoxicology. 2017 Jun 10;64:230–239. doi: 10.1016/j.neuro.2017.06.007

Table 1.

Body weight changes in mice after treated with Mn, VPA, NaB, Mn plus VPA, or Mn plus NaB for 21 days

Treatment Groups Day 1
Average Weight (g, n=8)
Day 21
Average Weight (g, n=8)
Weight
Gain (+)/Loss (−) (g)
Control 23.04 ± 1.77 26.58 ± 1.74 +3.55 ± 0.94
Mn 19.54 ± 3.47 18.11 ± 2.06 −1.43 ± 2.02
VPA 22.58 ± 1.27 24.60 ± 1.82 +2.03 ± 1.16
VPA + Mn 21.99 ± 0.85 22.02 ± 0.99 +0.03 ± 0.43
NaB 22.48 ± 1.19 23.45 ± 1.65 +0.97 ± 1.37
NaB + Mn 21.90 ± 1.73 20.07 ± 1.41 −1.83 ± 0.44

Mice were pretreated with VPA (100 μl/200 mg/kg, i.p. daily) or with NaB (100 μl/1200 mg/kg, i.p. daily) 30 min prior to Mn exposure (2 μl/30mg/kg, intranasal instillation, daily) for consecutive 21 days. Body weights were measured throughout the experiment and weight gain recorded on day 1 and day 21. Results represent mean ± S.E.M derived from eight independent experiments and each of their weights are expressed in grams (g). Statistical analysis was performed by two-way ANOVA repeated measures, followed by Tukey’s post-hoc test, (n=8).